Highlights OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
10.81 ^USD	-0.92%		+1.79%	-24.46%

Apr. 29	OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024	CI
Apr. 16	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024	Apr. 29	CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	Apr. 16	MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	Apr. 16	MT
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024	Apr. 16	CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop	Apr. 01	MT
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Mar. 27	CI
OptimizeRx Corp. Powers Walmart's ?Specialty Pharmacies of the Community? Outreach Effort	Mar. 04	CI
OptimizeRx Shares Jump as Preliminary 2023 Revenue Tops Guidance	Jan. 09	MT
OptimizeRx Corporation Revises Earnings Guidance for the Year 2023	Jan. 09	CI
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Nov. 14	CI
OptimizeRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q3 Revenue $16.3M, vs. Street Est of $15.1M	Nov. 06	MT
OptimizeRx Corporation Provides Earnings Guidance for the Year 2024	Nov. 06	CI
OptimizeRx Corporation Increases Earnings Guidance for the Year 2023	Nov. 06	CI
OptimizeRx Corporation completed the acquisition of Healthy Offers, Inc. from a group of shareholders.	23-10-23	CI
OptimizeRx Agrees to Acquire Medicx Health for $95 Million; Issues Q3 Non-GAAP Net Income, Revenue Expectations	23-10-12	MT
OptimizeRx Corporation Provides Preliminary Financial Guidance for the Third Quarter Ended September 30, 2023	23-10-12	CI
OptimizeRx Corporation signed an agreement to acquire Healthy Offers, Inc. for $95 million.	23-10-10	CI
OptimizeRx Expands Healthcare Professionals Engagement Platform Through New AI Offering	23-09-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights OptimizeRx Corporation

Equities

OPRX

US68401U2042

Highlights

Filters